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Zusammenfassung 
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Anne Kathrin Ebelt 
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 sekretariat@kltmed.ch  
 
 
 
Bestimmung der Blutgruppen DEA 1, DEA 4, DEA 5, Dal und Kai 1/Kai 2 bei 
reinrassigen Hunden in Deutschland 
 
 
 
Ziel: Reinrassige Hunde in Deutschland wurden mit Hilfe bewährter und neuer Kits/ 
Reagenzien hinsichtlich mehrerer Blutgruppen untersucht. Material und Methoden: EDTA-
Blutproben aus der Routine-Diagnostik wurden wie folgt untersucht: DEA 1 mittels 
immunochromatographischem Streifen; Dal, Kai 1 und Kai 2 mittels Gelsäulen; DEA 4 und 
DEA 5 mit neuen Agglutinationskarten sowie vergleichend zusätzlich mittels Gelsäulen. Für 
DEA 1 sowie Kai 1/Kai 2 wurden monoklonale und für die restlichen Blutgruppen 
polyklonale Antikörper verwendet. Resultate: Von 206 untersuchten Hunden waren 59,2% 
DEA 1+, 100% DEA 4+, 9% (Karte)/ 11% (Gel) DEA 5+, 89,3% Dal+, 96,6% Kai 1+ und 
2,9% Kai 2+. Keiner der Hunde war Kai 1+/2+ und lediglich einer war Kai 1-/2-. Bei den 
meisten DEA 1+ Hunden zeigte der Streifen eine stark positive Bindungsreaktion. Die DEA 4 
Resultate waren übereinstimmend positiv, während die DEA 5 Agglutinationskarten 
allgemein schwächere und weniger positive Reaktionen erbrachten. Dal- Hunde fanden sich 
in den Rassen Cane Corso, Dalmatiner, Dobermann, Lhasa Apso, Mastiff, Mops und Shih 
Tzu. 80% der Hunde zeigten ein übereinstimmendes Blutgruppenmuster und unterschieden 
sich lediglich hinsichtlich DEA 1. Schlussfolgerung: Diese erste europäische Studie von 
vielen caninen Blutgruppen zeigt eine ähnliche Verteilung wie in den USA. Die neueren 
Typisierungsmethoden haben sich bewährt und könnten zur Erkennung und Verhinderung 
von Blutgruppen-Unverträglichkeiten verwendet werden. 
 
Stichworte: Blutgruppe, Transfusionsreaktion, Polymorphismus, Hund, 
Blutgruppenunverträglichkeit 
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Summary 
 
 
Vetsuisse-Faculty University of Zurich 2020 
Anne Kathrin Ebelt 
Department of Small Animals, Clinic for Small Animal Internal Medicine, 
sekretariat@kltmed.ch  
 
 
 
Survey of Blood Groups DEA 1, DEA 4, DEA 5, Dal, and Kai 1/Kai 2 in Different Canine 
Breeds from a Diagnostic Laboratory in Germany 
 
 
 
Purpose: The distribution frequencies of purebred dogs in Germany were to be assessed using 
established or new clinical kits and results compared to prior studies. Material and Methods: 
Leftover anticoagulated blood samples were examined using an immunochromatographic 
strip method for DEA 1, a gel column technique for Dal and Kai 1/2, and new card 
agglutination tests for DEA 4 and DEA 5 (which were partially compared with the gel column 
technique). Monoclonal antibodies were used for DEA 1 and Kai 1/2 typing, and polyclonal 
antibodies were used for all other types. Results: Among the 206 dogs, 59.2% were DEA 1+, 
100% DEA 4+, 9% (Card)/11% (Gel) DEA 5+, 89.3% Dal+, 96.6% Kai 1+, and 2.9% Kai 
2+. None were Kai 1+/2+, and only one was Kai 1-/2-. Erythrocytes from most DEA 1+ dogs 
bound strongly on the strips. The agglutination reactions for DEA 5 on the new card tests 
were generally less than those on the gel column. Dal- dogs were found in several breeds. 
80% of the dogs showed the same blood group pattern only differing in DEA 1 type. 
Conclusions: The proportion of positive and negative blood types were similar to those found 
in the United States and for DEA 1 also similar to those from other European countries. The 
newer typing techniques seem to work well and will likely be useful to detect and prevent 
specific blood type incompatibilities in the clinic. 
 
Keywords: blood type, blood compatibility, transfusion reaction, polymorphism, dog 
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Survey of Blood Groups DEA 1, DEA 4, DEA 5, Dal, and Kai 1/Kai 
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Abstract 
More than twelve blood group systems have been described in dogs, but little is known about 
their distribution frequencies within breed populations. Here we report on an extensive typing 
survey carried out using available reagents and either established or new clinical kits in 
purebred dogs from Germany.  
Leftover anticoagulated blood samples were examined using an immunochromatographic 
strip method for DEA 1, a gel column technique for Dal and Kai 1/2, and new card 
agglutination tests for DEA 4 and DEA 5 (which were partially compared with the gel column 
technique). Monoclonal antibodies were used for DEA 1 and Kai 1/2 typing, and polyclonal 
antibodies were used for all other types.  
Among the 206 dogs, 59.2% were DEA 1+, 100% DEA 4+, 9% (Card)/11% (Gel) DEA 5+, 
89.3% Dal+, 96.6% Kai 1+, and 2.9% Kai 2+. None of the dogs were Kai 1+/2+, and only 
one was Kai 1-/2-. Dal- dogs were found in several breeds. Erythrocytes from most DEA 1+ 
dogs bound strongly on the strips. The agglutination reactions for DEA 5 on the new card tests 
were generally less than those on the gel column. The blood group pattern DEA 4+, DEA 5-, 
Dal+, Kai 1+/2- and either DEA 1+ or DEA 1- was found among 80% of the dogs.  
In this first extensive blood typing survey of purebred dogs from Europe, the proportion of 
positive and negative blood types were similar to those found in the United States and for 
DEA 1 also similar to those from other European countries, with considerable breed variation 
for blood types. The newer typing techniques seem to work well and will likely be useful to 
detect and prevent specific blood type incompatibilities in the clinic.
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1. Introduction 
Canine blood group systems are defined by the expression of various antigens on the surface 
of red blood cells (RBCs), with different individuals either missing a specific antigen 
(negative blood type) or expressing it to varying degrees (positive blood type) (1, 2). Because 
individuals lacking the expression of a certain antigen may develop transfusion reactions 
following subsequent transfusions due to naturally occurring or induced alloantibodies, 
accurate typing of canine blood types is essential to prevent potentially fatal blood 
incompatibility reactions in clinics (3-6) 
While canine blood groups have been studied for more than half a century (7, 8), none have 
been characterized at the biochemical and/or molecular genetic level. Instead, canine blood 
group systems, which now number more than a dozen, have been identified utilizing antisera 
from previously transfused dogs and/or the specifically generated monoclonal antibodies (1, 
9). An international committee meeting in the 1970s designated the initially identified blood 
group systems as Dog Erythrocyte Antigen – DEA (10). Since then additional blood group 
systems have been proposed, including Dal (11), Kai 1 and Kai 2 (12), and other currently 
unclassified blood groups (9). Moreover, additional blood group systems are suspected to 
exist based upon incompatible major crossmatch test results observed in previously transfused 
dogs (13). 
While some blood group systems are well accepted, there is still some controversy regarding 
the presence of clinically important naturally occurring alloantibodies against DEA 3, DEA 5 
and DEA 7 (2, 7, 14, 15). However, there have been no acute hemolytic transfusion reactions 
reported in dogs in clinical settings, and similarly no neonatal isoerythrolysis has been 
reported in puppies unless the dogs have been previously transfused (16, 17). Therefore, the 
presence and clinical importance of any naturally occurring alloantibodies are questioned. 
The blood group system DEA 1 is clinically considered most important due to the strong DEA 
1 antigenicity and the fact that DEA 1+ and DEA 1- dogs are found in relatively equal 
proportions (14, 18). The DEA 1 blood group system was originally proposed to have several 
subtypes; DEA 1.1 (A1), DEA 1.2 (A2) and DEA 1.3 (A3) (7, 8). However, recent studies 
indicate that the DEA 1 antigen(s) can be recognized by a single monoclonal antibody, with 
the antigen(s) variably expressed from weakly to moderately to strongly positive (19). The 
level of expression of DEA 1 antigen(s) is genetically determined and does not change over 
time or during storage of blood (19, 20).  
Blood typing methods have evolved from tube and card tests to immunochromatographic 
strip, cartridge, and flow cytometry assays, but additional typing kits for other blood types 
would be desirable (1, 21-24). Several limited surveys have been performed for DEA 1 and a 
few have assessed other blood types in North America and Europe (25-35) but there have 
been no comprehensive surveys carried out on canine populations typing for many blood 
groups. 
The purpose of this study was to determine the prevalence of several blood types in dogs 
using available reagents and kits at a diagnostic reference laboratory in Germany. We also 
determined the degree of DEA 1 antigen expression and introduced two novel typing kits, i.e. 
agglutination cards for DEA 4 and DEA 5. Finally, we compared our typing results to studies 
from USA and other countries. This represents the first extended blood typing survey in 
purebred dogs from Europe. 
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2.  Materials and methods   
2.1 Dogs and blood samples 
Leftover ethylene-diaminetetraacetic acid (EDTA)-anticoagulated blood samples from 
purebred dogs that had been submitted for routine diagnostic work to Laboklin GmbH& Co 
KG, Kissingen, Germany between December 2018 to October 2019 were used for this survey. 
Of a total of 206 samples the majority (188) originated from Germany, with 18 samples from 
neighboring or other European countries (Czech Republic, Denmark, Finland, Italy, 
Luxembourg, Sweden and Norway). The approval to use leftover samples for research was 
received from the IACUC of the Government in Bayern, Germany. Only leftover samples 
with at least 1 ml EDTA blood and less than 1 week old and stored at 4-8°C until analysis 
were included. Samples from several dog breeds, classified based on the Fédération 
Cynologique Internationale (FCI) were selected based upon prior studies (11, 12, 27, 29, 36, 
37) and our own early results of their varied blood group antigen expression. Samples from 
known related dogs or repeat samples from the same dog were excluded. Data on breed, 
gender, and age as well as geographic region were obtained. None of the samples showed any 
auto-agglutination by the card and the gel test. All results were photographically captured. 
2.2 Blood typing assays 
2.2.1 DEA 1 typing by immunochromatographic strip 
An immunochromatographic strip method (Strip, Lab Test DEA 1, Alvedia, Limonest, 
France) with a murine monoclonal anti-DEA 1 alloantibody was used according to 
manufacturer’s instructions and as previously described (19, 27). The strength of the DEA 1 
band was semi-quantitatively assessed by visually comparing the control (anti-glycophorin 
antibody) band to the DEA 1 band and grading it from - to 4+ (Figure 1), as previously 
described (27, 38). 
 
Figure 1 DEA 1 typing results with 
immunochromatographic strips from 
206 dogs  
The varied binding intensities to a 
monoclonal anti-DEA 1 antibody at the 
DEA 1 position on strip were graded from - 
(no band, negative) to 1+ to 4+ (band, 
positive). Red blood cells in suspension 
migrated in the membrane; the C (control) 
band had to show to be a valid test, while a 
variably strong DEA 1 band was visible in 
some case.
  
 
9 
2.2.2 DEA 4 and DEA 5 typing by agglutination cards 
Newly introduced agglutination cards (Card, RapidVet-H DEA 4 Agglutination Card Test and 
DEA 5 Card RapidVet- H DEA 5 Agglutination Card Test, DMS, Flemington, NJ, USA) with 
polyclonal anti-DEA 4 or anti-DEA 5 typing reagents (antisera) were used for this survey 
according to the manufacturer’s instructions, with minor modifications. Prior to utilizing these 
cards in this survey, they were validated with DEA 4+ and DEA 4- RBCs as well as with DEA 
5+ and DEA 5- RBCs, respectively, by the manufacturer. 
While the manufacturer’s instructions suggested the use of 40 µl diluent for DEA 4 typing, 
very weak agglutination reactions prompted us to add an additional 40 µl diluent after the 
initial reading, to achieve a total of 80 µl of diluent (identical to volume in protocol for DEA 5 
typing). This was routinely performed for 191 of 206 samples after the occurrence of weak 
agglutination reactions was observed with some of the first blood samples. The lack of and 
degree of an agglutination reaction was recorded from - to 4+ (Figure 2A). 
Briefly, 50 µl EDTA blood was added to 40 µl of diluent for DEA 4 typing or 80 µl diluent 
for DEA 5 typing in each of the three wells on one card. Using the provided wooden stirrer, 
the reagents adhering to both the positive control and the patient well surface were rubbed off 
(no reagent in auto-agglutination control) and mixed to cover the entire well. The cards were 
gently rocked for 30 seconds, and then examined for agglutination reactions first while still 
rocking and once again after slightly tilting the card to allow excess blood to run to the 
bottom of each well.  
If there were no visible agglutinations in the auto-agglutination well and a visible 
agglutination reaction in the positive control well, the assay was considered valid.  Depending 
on the presence or absence of an agglutination reaction in the patient test well, the dog is 
considered weakly (1+) to strongly positive (3+/4+) or negative (-) for the respective blood 
group (Figures 2B, 2C). 
 
Figure 2 New agglutination cards for DEA 4 
and DEA 5 typing of dogs  
(A) Grading of the agglutination reaction strength 
from - to 4+. (B) DEA 4+ and (C) DEA 5+ 
showing weak agglutination reactions (1+). In 
each of the three wells of a card 40 µl (DEA 4) or 
80 µl (DEA 5) of buffer and 50 µl of EDTA blood 
from one dog was added and gently mixed.  The 
well for ‘Auto-Agglutination-Saline Screen’ and 
‘Positive Control’ must be negative and positive, 
respectively, to interpret typing results.  
Depending on whether there is agglutination in 
‘Patient Test’ well the dog is considered positive 
or negative.  
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Any degree of agglutination was considered a positive typing result. While the agglutination 
card testing was performed with all samples, the gel column assay (see below) was also 
performed on some samples (n=158) using the same anti-DEA 4 and anti-DEA 5 
alloantibodies. 
 
2.2.3 DEA 4 and DEA 5, Dal, Kai 1 and Kai 2 typing by gel column technique 
A gel column technique (Gel, using BioRad ID-Cards, NaCl, Enzyme Test and Cold 
Agglutinins, DiaMed, Cressier, Switzerland) was used for DEA 4 and DEA 5, Dal, Kai 1 and 
Kai 2 typing similar to our previous studies (24, 27, 29, 39). Briefly, EDTA blood samples 
were washed three times and diluted to a 2% RBC suspension using phosphate buffered 
saline. Canine antisera containing anti-DEA 4 or anti-DEA 5 polyclonal alloantibodies from 
previously sensitized dogs (Animal Blood Resources International, Michigan, USA provided 
by DMS Laboratories Inc.) were diluted 1:32 and 1:10 with Blood Bank Saline, respectively. 
The anti-Dal alloantibody was from a previously sensitized dog (University of Pennsylvania 
(11)) and monoclonal alloantibodies against Kai 1 and Kai 2 (Dr. He Young Kim, South 
Korea (12)) were used undiluted. We added 25 µl of the 2% RBC suspension and 25 µl of 
alloantibody reagent on top of the gel column. The mixture was incubated for 15 minutes at 
room temperature (~23°C) and then the gel column cards were centrifuged for 10 minutes at 
85 x g in a ID-Centrifuge 6 S (DiaMed-ID, Microtyping System, DiaMed, Cressier, 
Switzerland). The results were then visually analyzed, and results were graded from - to 4+ 
(Figure 3) depending on the location of the majority of RBCs within the gel column as 
described (27, 29, 30).  
 
Figure 3 Gel column typing results 
for Dal, Kai 1, Kai 2, DEA 4, and 
DEA 5 from one dog 
The blood sample from this dog shows 
a common typing pattern: 4+ 
agglutination reactions for Dal and  
Kai 1, no agglutination for Kai 2,  
a 3+ agglutination reaction for DEA 4, 
and no agglutination for DEA 5.  Red 
blood cells at top (4+) to within the gel 
mean positive agglutination reactions. 
PBS, phosphate buffered saline serves 
as auto-agglutination control.
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2.3 Statistical analysis 
For statistical analyses, Python v. 3.5.2 using Scipy
1
 v. 0.17.0 and Numpy v. 1.11.0 were 
used. Chi- square test was done using Scipy’s Chi-square implementation. Results were 
considered significant when p<0.05. Additionally, for comparison of DEA 4 and DEA 5 Card 
and Gel Test the Cohen Kappa- Test using Scikit v. 0.17.0 was used.  
3. Results  
In this survey we screened 206 dogs from 18 breeds of 6 FCI groups, with ≥10 dogs for 9 
breeds (Supplement Table 1 and Table 1). There were 53.9% males and 43.7% females (2.4% 
unknown). The age of the dogs ranged between 0.4 to 17 years (age unknown for nine dogs).  
Of the 64 (2
6
) possible blood type combinations, 14 different patterns were found, with two 
predominant patterns that only differed by DEA 1 type; 47% of the dogs were DEA 4+, DEA 
5-, Dal+, Kai 1+, Kai 2-, DEA 1+, and 33% were DEA 4+, DEA 5-, Dal+, Kai 1+, Kai 2-, 
DEA 1-, thus 80% only differed by their DEA 1 type. The other 12 observed blood type 
patterns were seen in only 0.5% to 5% of the dogs, without any specific breed association 
(patterns shown in Supplement Table 2). 
 
Supplement Table 1 Typing results from 9 additional breeds with <10 dogs  
These 14 dogs were summarized as ‘9 breeds with <10 dogs’ in Table 1  
Breed ( FCI
1
 Group) 
Number of 
dogs 
% of all 
dogs tested 
DEA 1+  Dal+  
DEA 4+ 
Card 
Kai 1+/ 
Kai 2- 
Bergamasco Shepherd Dog (1) 1 0.49 1  0 1 1 
Bullmastiff (2) 1 0.49 1  1  1 
1 
  
Chihuahua (9) 3 1.46 3  0 3 3 
Coton de Tulear (9) 1 0.49 1 0  1 
1 
  
Flat Coated Retriever (8) 1 0.49 0 0 1 
1 
  
Giant Schnauzer (2) 2 0.97 2 0  2 2  
Havanese (9) 2 0.97 1  0 2 2 
Malinois (1) 2 0.97 1  0 2 2  
Staffordshire Bullterrier (3) 1 0.49 0 0 1 1  
Total 14 
6.8 
10 1 14 14 
% 100 71.4 7.1 100 100 
 
 
There were no DEA 5+, Kai 1-/Kai 2+, Kai 1-/Kai 2- dogs. 
All dogs tested were also DEA 4+ with gel column method. 
1
Fédération Cynologique Internationale; DEA Dog Erythrocyte Antigen 
 
 
1 https://www.scipy.org  
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Table 1 Typing results for blood groups DEA 1, Dal, DEA 4, DEA 5, Kai 1 and Kai 2 in 206 dogs from Germany including breed and FCI
1
 
group Immunochromatographic strip, agglutination card, and gel column technique were used. Several blood group patterns were found (s. S.T. 2) 
 Dogs Canine Blood Groups 
Breed (FCI
1
 Group) N
a 
%
b DEA 1+ 
(%) 
Dal+  
(%) 
DEA 4+ 
Card
2 
DEA 5+  
Card          Gel 
Kai 1+/ 
Kai 2- 
Kai 1-/ 
Kai 2+ 
Kai 1-/ 
Kai 2- 
Cane Corso (2) 21 10.19 
6 
  (28.6)
3 
18 
(85.7) 
21 
(100) 
2 
 (9.5) 
2/15 
 (13.3) 
21  
(100) 
0 
(0) 
0 
(0) 
Dalmatian (6) 21 10.19 
20 
 (95.2)
3,4 
18 
 (85.7) 
21 
(100) 
4 
 (19.0) 
2/14 
  (14.3) 
21 
 (100) 
0 
(0) 
0 
(0) 
Dobermann (2) 21 10.19 
5 
 (23.8)
3 
16  
(76.2) 
21 
(100) 
5 
 (23.8) 
6/13 
 (46.2)
5 
21 
 (100) 
0 
(0) 
0 
(0) 
Labrador Retriever (8) 26 12.62 
19 
(73.1)
6 
26  
(100) 
26 
(100) 
0 
 (0) 
0/20 
 (0) 
26 
 (100) 
0 
(0) 
0 
(0) 
Lhasa Apso (9) 21 10.19 
12 
 (57.1) 
18 
 (85.7) 
21 
(100) 
2 
 (9.5) 
2/18 
 (11.1) 
16 
(76.2) 
5  
(23.8) 
0 
(0) 
Maltese (9) 28 13.59 
13 
 (46.4) 
28  
(100) 
28 
(100) 
6 
 (21.4) 
5/23 
 (21.7)
5 
26 
 (92.9) 
1 
 (3.6) 
1 
 (3.6) 
Pug (9) 20 9.71 
20 
(100)
3,4 
18 
 (90.0) 
20 
(100) 
0 
 (0) 
0/20  
(0) 
20 
 (100) 
0 
(0) 
0 
(0) 
Shih Tzu (9) 24 11.65 
16 
 (66.7) 
19 
 (79.2) 
24 
(100) 
0 
 (0) 
0/21 
 (0) 
24 
 (100) 
0 
(0) 
0 
(0) 
Boxer (2) 10 4.85 
1 
(10.0)
3 
10  
(100) 
10 
(100) 
0  
(0) 
1/8  
(12.5) 
10 
(100) 
0 
(0) 
0 
(0) 
9 breeds with <10 dogs
7
 14 6.79 
10 
 (71.4) 
13 
 (92.9)
8 
14 
(100) 
0 
 (0) 
0/6 
 (0) 
14 
 (100) 
0 
(0) 
0 
(0) 
Total Number (N) 206 122 184 206 19 18
9 
199 6 1 
% 100 59.2 89.3 100 9.2 11.4 96.6 2.9 0.5 
1
Fédération Cynologique Internationale;  
2
also all 158 dogs tested with Gel were DEA 4+;  
3
correlation between breed and DEA 1 blood type was significant (p< 
0.05); 
4
significantly stronger reactions for DEA 1 were found; 
5
correlation between breed and DEA 5 blood type was significant (p< 0.05); 
 
6
significantly weaker/more moderate reactions for DEA 1 were found;  
7
Details are presented in Supplement Table 1; 
8
1/1 Dal- Bullmastiff; 
9
158 of 206 samples were DEA 5 typed by Gel; N
a 
Number of dogs; %
b
 % of all 206 dogs; 
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Supplement Table 2 Prevalence (%) for blood type patterns from 206 dogs for blood 
types DEA 1, DEA 4, DEA 5, Dal, Kai 1 and Kai 2 
Blood Type % of dogs 
showing that pattern DEA 1 DEA 4 DEA 5 Dal Kai 1 Kai 2 
+ + - + + - 47.09 
- + - + + - 33.50 
+ + - - + - 4.85 
+ + + + + - 3.88 
- + - - + - 3.40 
- + + + + - 2.43 
+ + - + - + 0.97 
+ + + - + - 0.97 
- + - - - + 0.49 
- + + - + - 0.49 
- + + + - + 0.49 
+ + - - - + 0.49 
+ + + + - - 0.49 
+ + + + - + 0.49 
+ positive for tested blood type; 
- negative for tested blood type.  DEA Dog Erythrocyte Antigen 
 
3.1 DEA 1 typing results 
Utilizing the Strip with a monoclonal anti-DEA 1 alloantibody, we were able to identify dogs 
with no reactivity, and thus DEA 1-, as well as dogs that were strongly positive, with DEA 1 
bands comparable to the positive control band. Of the 206 dogs, an equal proportion was 
either graded as DEA 1- (40.8%) or strongly DEA 1+ (40.3%) with a smaller proportion 
(18.9%) of weak to moderate DEA 1+ band reactions (Figure 1). Strong reactions (3+ and 4+) 
for DEA 1 were found significantly more often in Dalmatians (p=0.0003) and Pugs 
(p=0.0003) and weak/moderate (1+/2+) reactions were significantly more common in 
Labrador Retrievers (p=0.001). All Pugs and Dalmatians except for one Dalmatian were DEA 
1+, and more Labrador retrievers and Shih Tzus were DEA 1+ than were other breeds (Table 
1).  
In contrast, less than a quarter of Cane Corsos and Doberman Pinschers were DEA 1+, and all 
but one Boxer were DEA 1- (Table 1). These breeds belong to the FCI group 2. A significant 
dependency between breed and DEA 1 type was found for Cane Corso (p=0.004), Dalmatian 
(p=0.001), Doberman Pinscher (p=0.001), Pug (p=0.0002), and Boxer (p=0.002).
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3.2 DEA 4 typing results 
When using the Card newly developed for DEA 4 typing according to manufacturer’s 
instructions, 9.2% of 206 dogs showed an extremely weak and thus questionable 1+ 
agglutination reaction, and 67.0% produced only weakly positive (1+/2+) results. However, 
when adding an additional 40 µl of diluent, all 191 tested dogs produced at least 1+ and 
clearly visible agglutination reactions, supportive of a DEA 4+ blood type. When comparing 
the results between the two diluent concentrations, 72% of the reactions stayed the same, 18% 
became stronger and 10% turned weaker (never differing by more than one degree, e.g. 2+ 
turned 1+), but none of the positive agglutination reactions turned negative (Supplement 
Table 3). Based on these results, the manufacturer’s instructions have been changed to 
indicate that if the results using the initial 40 µl are unclear, another 40 µl of diluent should be 
added. 
 
Supplement Table 3 Comparison of the agglutination strength on DEA 4 agglutination 
cards depending on using 40 µl or 80 µl buffer. When adding another 40 µl buffer to the 
initial 40 µl buffer used for the DEA 4 cards, the intensity did not change in most reactions, 
became stronger by 1 to 2 grades in 18% and 1 degree less in 10% of the reactions of the 191 
samples tested. It is important to note, that reactions that were very weak turned clearly 
positive when using 80 µl instead of 40 µl buffer. 
Reaction intensity with 80 µl                   
compared to 40 µl buffer 
N % 
Stronger 35 18.3 
Same 137 71.7 
Weaker 19 10.0 
 
 
To further evaluate results obtained by the new DEA 4 typing card, we also applied the Gel 
using commercially available anti-DEA 4 alloantibodies (antiserum; same as for Card). As all 
dogs tested were DEA 4+ with Card and Gel we had perfect agreement (Kappa= 1) of the 
tests. Of the 158 dogs tested, all reacted strongly positive (3+/4+) and, therefore, were 
considered to have blood type DEA 4+ (Fig 3). While all agglutination reactions observed by 
the Gel were 3+ to 4+, such strong reactions (3+ to 4+) using Cards were only seen in 23.8% 
and 15.7% using 40 µl and 80 µl diluent, respectively. While the regression of DEA 4 
agglutination strength with 40 µl and 80 µl in the 191 tested dogs showed a good correlation 
(r= 0.8999), there was no significant correlation of strength between Gel and Card (r= 
0.0754). Also, the degree of DEA 4 positivity did not appear to be associated with any 
particular breed. 
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3.3 DEA 5 typing results 
When using the new DEA 5 typing card according to manufacturer’s instructions, 90.8% of 
206 dogs did not show any RBC-agglutination reactions. Weak agglutination reactions (1+ or 
2+) were seen in 19 dogs and were thus considered DEA 5+ (Table 1). The manufacturer 
states that the DEA 5 agglutination is “finer and less plentiful than that observed in a DEA 1 
dog run on a DEA 1 test card” (DMS) and we also found the DEA 5+ card agglutination 
results to be consistently less intense than the DEA 4+ card results. Utilizing the Gel with the 
same polyclonal DEA 5 antibody used for the Card, 11.4% of the 158 dogs typed DEA 5+. 
With the Gel six (33.3%) of the DEA 5+ dogs reacted only weakly/moderately positive, while 
the other 12 DEA 5+ dogs reacted strongly (3+/4+).  
When comparing the Card and Gel methods 97% of the DEA 5 results were concordant; in 
four of five discordant results the Gel test indicated DEA 5+ (Table 2). The regression of 
DEA 5 Gel and Card strength in all 158 tested dogs showed a good correlation (r=0.8329) and 
the two methods showed almost perfect agreement (Kappa =0.831). For the Doberman 
Pinscher (p=0.02) and Maltese (p=0.03) the DEA 5+ blood type was significantly associated 
with the breed. 
Using the Card, 9% of all 206 dogs and also 9% of the 158 dogs that were typed by both card 
and Gel were DEA 5+, while 11% of those 158 dogs were DEA 5+ using the Gel. DEA 5+ 
dogs were found by Card and by Gel in Cane Corso, Dalmatian, Doberman, Lhasa Apso, 
Maltese, and by Gel also in one Boxer (Table 1).  
 
Table 2: Comparison and results for DEA 5 Card and Gel for 158 dogs typed by both 
methods  
N = 158 
Gel DEA 5 Typing Results 
DEA 5+  DEA 5-  
Card DEA 5 Typing Results   
DEA 5+ 14 1 
DEA 5- 4 139 
Gel DEA 5 Typing Results     N (%) 18 / 11.39%* 140 / 88.61% 
Card DEA 5 Typing Results   N (%) 15 / 9.49% 143 / 90.51% 
    
3.4 Dal typing results 
Strong (3+/4+) agglutination reactions for Dal using a polyclonal anti-Dal antiserum in a Gel 
assay were observed in 183 of the Dal+ dogs, and a 2+ reaction was seen in one Shih Tzu 
which was on immunosuppressive therapy. In addition to the previously reported breeds with 
Dal- dogs, we found 22 Dal- dogs also in the breeds Cane Corso, Pug, and Mastiff (Table 1). 
We did not find any significant association between breed and Dal type, but the number of 
dogs per breed is small.
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3.5 Kai 1 and Kai 2 typing results 
Utilization of the Gel and specific monoclonal antibodies against Kai 1 and Kai 2 resulted in 
either very strong agglutination reactions or completely negative test results (Figure 4). 
Overall, 96.6% of all dogs were Kai 1+/Kai 2- (Table 3). There were only five Lhasa Apsos 
and one Maltese that were Kai 1-/Kai 2+. Furthermore, only a single Maltese dog was found 
to be Kai 1-/Kai 2- in this survey. (Table 1)  
 
Table 3: Results for Kai 1 and Kai 2 typing of 206 dogs typed by gel column method  
N (%) Kai 1+ Kai 1- 
Kai 2+ 0 (0) 6 (2.9) 
Kai 2- 199 (96.6) 1 (0.5) 
 
 
Figure 4 Gel column typing results for 
the same six dogs for Kai 1 and Kai 2  
Dogs A-D and F are showing the most 
common Kai 1+/Kai 2- typing pattern, 
while Dog E has a Kai 1-/Kai 2+ pattern. 
 
 
 
 
4. Discussion 
Blood transfusions are pivotal in the supportive care of anemic and bleeding dogs, but the 
recruitment of blood donors and assuring blood type compatibility pose challenges. While 
DEA 1 typing is well established, limited availability of other typing reagents, in-practice kits, 
and laboratory methods have hampered the extended blood typing of dogs. In this 
comprehensive blood typing survey of 206 dogs from Germany, we used established and 
introduced new typing methods for several canine blood types and found significant 
differences in the prevalence of specific blood types among certain breeds. Overall, 80% of 
all dogs were DEA 4+, DEA 5-, Dal+, and Kai 1+/2-, but could be either DEA 1+ or DEA 1-. 
While Gel and Strip are the most accurate standardized methods, the new DEA 4 and DEA 5 
typing cards are welcome diagnostic kits to extend the typing repertoire in clinical practice 
and assist with the investigation and prevention of blood incompatibilities.
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4.1 DEA 1 typing 
Overall 40.8 % of all dogs in our survey were DEA 1-, which is very similar to recent surveys 
from USA, India and Italy that also utilized the same immunochromatographic method and 
monoclonal anti-DEA 1 alloantibody (25, 27, 31, 37, 40). Comparison to prior studies is 
complicated because these studies utilized polyclonal alloantibodies against DEA 1.1 and 
DEA 1.2 (7). However, recent studies clearly showed a close association between DEA 1 
typing and DEA 1.1 typing results (19). In fact, the original monoclonal anti-DEA 1.1 
alloantibodies used in DEA 1 typing kits were later renamed as DEA 1 by the manufacturers. 
The relationship between DEA 1 and DEA 1.2 is less clear, but it is likely that DEA 1.2 is a 
weaker DEA 1 antigen (20). No laboratories currently offer DEA 1.2 typing or any reagents 
for DEA 1.2 typing. Nevertheless, prior surveys using polyclonal anti-DEA 1.1 and anti-DEA 
1.2 antisera also showed a predominance of DEA 1+ dogs (Table 4). A comparative overview 
of prior DEA 1 typing surveys is shown in Table 4.  
Far more (71-90%) tested Cane Corsos, Doberman Pinschers, and Boxers were DEA 1-. 
Interestingly, these breeds belong to the FCI group 2, while other breeds studied were in other 
groups. Boxers and Cane Corsos from various other European countries and South Africa 
were also mostly DEA 1- in prior surveys (details in Supplement Table 4). Thus, these breeds 
may be preferentially considered when recruiting blood donors to increase the DEA 1- donor 
pool as suggested previously (25, 41)  
In contrast, Dalmatians and Pugs in our survey were all DEA 1+, except for one Dalmatian. 
Also, the Labrador Retriever and Shih Tzu breeds had mostly DEA 1+ dogs. The 
predominance of DEA 1+ dogs in these breeds was also observed in recent surveys from 
Switzerland, South Africa, Portugal and India (details in Supplement Table 4). Finally, the 
Maltese breed had a near equal proportion of DEA 1+ and DEA 1- dogs as previously 
reported from another survey in Italy (31). Thus, these DEA 1 typing surveys show worldwide 
similar proportions of DEA 1+ and DEA 1- dogs in each breed which is not surprising 
considering their common ancestors and international breeding practices within breeds. 
The strength of DEA 1 expression in DEA 1+ dogs is similar to a prior survey from the USA 
(27). Equal proportions are either strongly DEA 1+ or DEA 1-. Only a fifth of dogs showing 
weak or moderate DEA 1 expression, an important observation for clinical practice, as the 
latter may lead to difficulties in interpretation and potentially in sensitizing dogs. Indeed, even 
blood from a weakly DEA 1+ donor given to a DEA 1- dog can elicit the sustained production 
of anti-DEA 1 alloantibodies (38), and sensitized dogs may develop an acute hemolytic 
transfusion reaction (14).
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Table 4 Comparative table for own survey and previously reported DEA 1 blood type 
prevalence per region 
Number of Dogs  DEA 1+ (%) Region Reference Method 
206
* 
59.2 Germany
 
This Survey Strip
1 
66 69.7 North America  (19) Strip
1 
88 55 North America (24) Gel
4 
1037 62 Italy (25) Strip
1 
178 65.2 Turkey (26) Gel
4 
503 59.6 North America (27) Strip
1 
274 56.9 Portugal (28) Gel
4 
43 53.5  North America (30) Gel
4 * 
7414 61.2 Italy (31) Strip
1
, Card
2 
206 53.4 Spain (32) Cartridge
3 
304 53 Switzerland (33) Gel
4 
92 75 Spain (Ibiza) (34) Card
2 
233 47 South Africa (35) Card
2 
80 / 79 78.7
1
 / 57.0
1 
North America (37) Strip
1 
23 56.5
1
 / 39
2
   North America (39) Card
1
, Gel
2
, 
* 
125 61.6 India (40) Strip1 
100 78 South Africa (46) Strip
1 
1
Canine Quick Test/Lab Test BT DEA 1, Alvedia ,  
2
Card RapidVet-H Canine DEA 1.1, DMS 
Laboratories 
3
QuickTest DEA 1.1, Alvedia,  
4
ID- Gel Test DEA 1.1, DiaMed (
*
other methods not shown)   DEA 
Dog Erythrocyte Antigen 
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Supplement Table 4 Comparative table of DEA 1 prevalence in previous studies in 
breeds with ≥10 dogs in the current study per region 
Breed Number of dogs DEA 1+ Region Reference Methods 
Boxer 10 10% Germany This Survey Strip1 
 22 18% Italy (25) Strip
1 
 13 0% Portugal (28) Gel
3 
 
106 17% Italy (31) Strip1,Card2 
  8 0% Switzerland (33) Gel
3 
  8 13% South Africa (35) Card2 
Cane Corso 21 29% Germany This Survey Strip1 
  31 32% Italy (25) Strip1 
 
76 50% Italy (31) Strip1,Card2 
 46 29% Italy (41) Strip1 
Dalmatian 21 95% Germany This survey Strip1 
 
4 75% Switzerland (33) Gel3 
  4 100% South Africa (35) Card2 
  6 50% India (40) Strip1 
Doberman 21 24% Germany This Survey Strip1 
 17 6% Italy (25) Strip1 
 
12 0% Portugal (28) Gel3 
 
6 33% Switzerland (33) Gel3 
  5 60% South Africa (35) Card2 
  10 80% India (40) Strip1 
Labrador Retriever 26 73% Germany This Survey Strip1 
  69 77% Italy (25) Strip1 
  29 45% Portugal (28) Gel3 
 
478 65% Italy (31) Strip1,Card2 
 
20 75% Switzerland (33) Gel3 
  20 55% South Africa (35) Card2 
  44 59% India (40) Strip1 
Maltese 28 46% Germany This Survey Strip1 
 
4 75% Italy (25) Strip1 
 
130 55% Italy (31) Strip1,Card2 
  2 50% Switzerland (33) Gel3 
Pug 20 100% Germany This Survey Strip1 
 
4 100% Italy (25) Strip1 
 
61 77% Italy (31) Strip1,Card2 
Shih Tzu 24 67% Germany This Survey Strip1 
 
79 72% Italy (31) Strip1,Card2 
 
1Canine Quick Test/Lab Test BT DEA 1, Alvedia ,  2Card RapidVet-H Canine DEA 1.1, DMS Laboratories 
3ID- Gel Test DEA 1.1, DiaMed DEA Dog Erythrocyte Antigen 
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4.2 DEA 4 typing 
All dogs of this survey were typed as DEA 4+ by Gel and Card. Only few prior typing 
surveys included DEA 4 typing, and these studies also revealed that almost all dogs are DEA 
4+, as DEA 4- dogs are extremely rarely observed (7, 16, 27, 30, 37, 39). Thus, while DEA 4 
is known as a blood group system, it should be considered a high frequency antigen, as less 
than 1% of dogs are DEA 4- (14, 42).  
The new DEA 4 typing card test was easy to perform, but some results were challenging to 
interpret. Agglutination reactions on the Card were weaker than those observed with the Gel. 
As the addition of another 40 µl diluent enhanced the weak agglutination reactions, this 
phenomenon might be caused by a Prozone-like effect but was not further studied. The varied 
degree of agglutination reactions observed with the Cards remain unexplained but are likely 
technical, as all 158 dogs tested produced strongly positive (3+ to 4+) results by Gel. 
Optimization of the Card to increase agglutination reactions would enhance the reliability of 
this assay. In the meantime the manufacturer has independently adjusted the protocol based 
upon our observations. 
Because the instructions are identical to DEA 1 typing cards, the DEA 4 cards can be readily 
added to the typing repertoire in clinical practice. The DEA 4 typing cards may be particularly 
useful for clinical diagnostics of incompatibility reactions in previously transfused DEA 4- 
dogs and for identifying DEA 4- donors. Indeed, early experimental studies (8) reported blood 
incompatibilities caused by DEA 4+ alloantibodies, and there is one clinical case report of an 
acute hemolytic transfusion reaction after the dog had been sensitized by a prior DEA 4+ 
transfusion (4). Thus, identifying DEA 4- donors could be very valuable when facing broad 
blood incompatibilities in previously transfused dogs potentially caused by DEA 4 
sensitization. 
 
4.3 DEA 5 typing 
In this survey from Germany we found 9% and 11% DEA 5+ dogs with Card and Gel, 
respectively. Similarly, a limited survey from the Netherlands identified 17% DEA 5+ (43) 
and other surveys from North America found 12-25% DEA 5+ dogs (14, 16). Although DEA 
5 had been associated with blood type incompatibilities and reduced RBC lifespan 
experimentally (8), there are no clinical reports of any acute hemolytic transfusion reactions 
related to DEA 5. The new DEA 5 typing cards will be useful in the practical diagnostic 
examination of blood type incompatibilities and acute hemolytic transfusion reactions in 
previously transfused dogs.  
Finally, the new commercially available DEA 4 and DEA 5 typing cards used in this survey 
produced similar but weaker agglutination results to the gel column method. Moreover, the 
agglutinations were weaker than seen with the commonly used DEA 1 cards. Nevertheless, 
there was strong correlation between the two methods with only five discordant DEA 5 typing 
results, supporting their use in clinical settings.
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4.4 Dal typing 
While original reports suggested that the Dal- blood type was exclusive to Dalmatians (11), 
recent studies from North America also found Dal- dogs in other breeds (27, 29, 36). 
Similarly, our survey from Germany found 10.7% Dal- dogs. This includes dogs from breeds 
with previously described Dal- dogs like Dalmatians, Dobermans, Shih Tzu, Lhasa Apso (27, 
29, 36) and also for the first time in Cane Corsos, Pugs and a Mastiff. The prevalence of Dal- 
dogs in specific breeds is difficult to compare, because of the small numbers of dogs in each 
breed typed and reported geographical differences for the prevalence of Dal (29). Clearly, Dal 
typing is warrantied for those breeds as well as for additional breeds, as Dal type blood 
incompatibility could potentially lead to an acute hemolytic transfusion reaction (29). Thus, it 
would be beneficial to identify Dal- donors for use in Dal- patients.  Unfortunately, at this 
point there is no commercial Dal typing kit available. 
While the Gel uniformly showed strong (3+/4+) agglutination reactions with Dal+ blood, 
there was one dog which was receiving long term treatment with immunosuppressives with 
only a 2+ reaction. It may be possible that immunosuppression is reducing the expression of 
the Dal antigen or the binding with the antibody. Differences in antigen expression have been 
shown in humans with illnesses (44) and were suspected in FeLV+ cats (45).  
 
4.5 Kai 1 and Kai 2 typing 
Utilizing the Gel, the agglutination reactions were very strong for Kai 1 and Kai 2. In this 
survey, 96.6% of all dogs were Kai 1+/Kai 2-, and only few dogs were Kai 1- and Kai 2+ or 
Kai 2-. Thus, our studies of Kai 1 /Kai 2 blood type pattern distribution were similar to a prior 
survey from North America which found 94% Kai 1+/Kai 2-, 5% Kai 1-/Kai 2-, and 1% Kai 
1-/Kai 2+ (27). In a recent survey using the conventional tube agglutination assay with 203 
mostly Mastiff dogs from South Korea, the proportion of Kai 1+/Kai 2- was only 42%, with 
the proportion of Kai 1-/Kai 2+ being 37% and that of Kai 1-/Kai 2- being 20% (12). The 
large group of Kai 1-/Kai 2+ Mastiffs seen in Korea could not be substantiated here and in the 
survey from North America, because of lack of samples received from this breed. 
Noteworthy, however, is the absence of dogs that were Kai 1+ and Kai 2+. While the Kai 1 
and Kai 2 antigens appear to be very different based on protein size (12), it cannot be 
excluded that these two antigens are genetically related.  
Finally, several Lhasa Apsos were found to be Kai 1- /Kai 2+ in the United Kingdom 
(Watson, C.C. Euler, U. Giger, unpublished data, 2016). Because the only other Kai 1-/Kai 
2+ dog was a Maltese and another Maltese was Kai 1-/ Kai 2-, it is possible that these two 
related breeds of FCI Group 9 are unique regarding their Kai antigen expressions.  
However, the clinical importance of Kai 1 and Kai 2 blood groups needs to be further 
investigated, especially since the development of alloantibodies against Kai 1 and Kai 2 in 
previously transfused dogs has been reported (12). 
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4.6 Limitations 
Although this is the first published survey for Dal, Kai 1, and Kai 2 in Europe, it was 
primarily limited to Germany geographically. While over 200 dogs were typed for many 
blood types, the reported blood type prevalences for each breed are still limited by sample 
size. The prevalences could well be impacted, if more dogs are typed, and/or if dogs from 
other geographic regions are included. Because several reagents for typing are not readily 
available, and the clinical importance of some of the blood types tested has not been 
established, larger surveys are unlikely to be done.  
This study was performed under strict laboratory conditions in a reference diagnostic 
laboratory, with the same trained personnel (AE, SF) performing all the tests and with 
appropriate control samples. Typing conditions in private practice are likely to be less 
favorable, and weak agglutination and binding reactions will be difficult to interpret. When 
uncertain, blood samples should be sent to a reference laboratory for retyping and potentially 
back-typing if possible.  
Notably, this study did not evaluate the presence of naturally occurring alloantibodies in any 
dogs. However, the presence of naturally occurring alloantibodies has been evaluated in prior 
studies (12, 15, 16, 27, 29, 30), and they do not appear to cause acute hemolytic transfusion 
reactions when transfusing a dog for the first time (1, 8). Specific alloantibody studies of 
plasma or serum from previously transfused dogs, which were extensively typed as in this 
survey, would be of interest, although only rarely a known RBC antigen is identified to cause 
a hemolytic transfusion reaction (3, 4, 14). 
This study excluded typing for DEA 7, because commercial reagents were not available at the 
time this survey was performed, and in the past the available typing reagents have given DEA 
7 typing and alloantibody results that have been difficult to reproduce (27). Therefore, the 
presence of naturally occurring anti-DEA 7 alloantibodies and their importance in eliciting an 
acute hemolytic transfusion reaction independent of whether a dog was previously transfused 
or not remains unclear (7, 8, 14, 15, 41, 42). 
 
4.7 Conclusions 
The options for extended in house typing including the two now commercially available DEA 
4 and DEA 5 cards may be especially useful in previously transfused dogs, as well as in blood 
incompatibility work up in a practice setting. While in house typing reduces the turnaround 
time, tests should always be performed by trained personnel and, in the case of uncertain 
results, retyping and back-typing should be performed in a reference laboratory. Additional 
typing for Dal, Kai 1/2 with Gel should remain restricted to reference laboratories for now. 
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DiaMed) 
‘RBC’ red blood cell 
‘Strip’ immunochromatographic strip technique, (Alvedia, Lab Test DEA 1, Limonest, 
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